Search

2 January 2025 - The Medical Treatment Overseas Program (MTOP) helps approved Australians who have a life-threatening medical condition access life-saving medical treatment overseas where treatment is not available in Australia.

11 April 2025 - Find out how we define and monitor cases of rabies, and where you can learn more about this disease.

17 June 2025 - Learn about what is, and what is not an active ingredient in prescription medicines.

16 June 2025 - This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80165F) in subgroup 3(b) of the Stoma Appliance Scheme (SAS) Schedule.

11 April 2025 - Find out how we define and monitor cases of measles, how you can get vaccinated, and where you can learn more about this disease.

17 June 2025 - Active ingredient prescribing (AIP) is mandatory for most prescription medications listed on the Pharmaceutical Benefits Schedule (PBS) and the Repatriation Schedule of Pharmaceutical Benefits (RPBS).

11 April 2025 - Find out how we define and monitor cases of smallpox, and where you can learn more about this disease.

17 June 2025 - This outcomes register is a record of the Active Ingredient Prescribing Working Group (AIPWG) review of specific medicines from 1 January 2023.

11 April 2025 - Find out how we define and monitor cases of TB, and where you can learn more about this disease.

15 August 2022 - The Australian Government has launched the latest phase of the COVID-19 campaign to inform Australians that COVID-19 oral antiviral treatments are available for eligible cohorts.